HOW AGO TUMOR CAN SAVE YOU TIME, STRESS, AND MONEY.

Hormonal therapy remains the remedy of initially choice for metastatic individuals with endocrine-responsive breast cancer (LoE 1a A, AGO ++). The sequential use of the readily available medicines is determined by the individual pretreatment. Reassessment of ER, PR, and HER2 in tumor tissue at time of analysis of relapse is suggested Every time doa